Back
Voyager Therapeutics 10K Form
Sell
21
VYGR
Voyager Therapeutics
Last Price:
6.49
Seasonality Move:
-14.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VYGR News And Ratings
See the #1 stock for the next 7 days that we like better than VYGR
VYGR Financial Statistics
Sales & Book Value
| Annual Sales: | $250.01M |
|---|---|
| Cash Flow: | $-32.55M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.16 |
| Price / Book: | 1.01 |
Profitability
| EPS (TTM): | 0.22000 |
|---|---|
| Net Income (TTM): | $9.02M |
| Gross Margin: | -- |
| Return on Equity: | 3.5% |
| Return on Assets: | 2.42% |
Voyager Therapeutics Earnings Forecast
Key Voyager Therapeutics Financial Ratios
- The Research & Development expenses have been 36.87% of Revenue.
- The Net Earning history of VYGR is 52.93% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 5 years.
Voyager Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VYGR |
| CUSIP: | 92915B |
| Website: | voyagertherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.51 |
| Quick Ratio: | 9.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.1 |
|---|---|
| Forward P/E Ratio: | 0 |
VYGR Technical Analysis vs Fundamental Analysis
Sell
21
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy or a Sell?
-
Voyager Therapeutics stock is rated a Sell
The current Voyager Therapeutics [VYGR] share price is $6.24. The Score for VYGR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.